Breaking News
Get 40% Off 0
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For Free Copy Portfolio
Close

ArthroCare Corporation (ARTC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow ArthroCare's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ArthroCare historical data, for real-time data please try another search
48.60 0.00    0.00%
29/05 - Closed. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 48.60 / 48.65
  • Day's Range: 48.56 - 48.61
Type:  Equity
Market:  United States
ArthroCare 48.60 0.00 0.00%

ArthroCare Company Profile

 
Read the ArthroCare Corporation company profile to learn more about the business and the management team. View ArthroCare Corporation facts about employee data, company products and services, and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

1840

ArthroCare Corporation, a medical device company, develops, manufactures, and markets surgical products based on its Coblation technology in the Americas and internationally. It offers sports medicine products, including Coblation Wands that features disposable energy-based surgical wands for single patient use to treat shoulder, knee, hip, foot, ankle, elbow, and wrist injuries; and soft-tissue fixation products, such as knotless and traditional anchors for rotator cuff and labrum repairs in the shoulder and hip; screws for ligament reconstruction in the knee; and arthroscopic suture passers, as well as reusable hand-held instruments, procedural kits, and accessories. The company also provides ear nose and throat products consisting of suction wands, channeling wands, and excision wands; ENTact septal stapler for reattaching nasal mucosal flaps; SerpENT articulating instruments, which include cutting and grasping tools; and Ventera sinus dilation systems. In addition, it offers carboxymethyl-cellulose based packing and tamponade products, such as Rapid Rhino product line; dissolvable Stammberger sinus dressing and sinu knits to control minor bleeding, facilitate epithelial healing, and preserve the spatial integrity of the sinus area; and epistaxis balloon tamponade products for the hospital emergency room environment to control severe nosebleeds. Further, the company provides SpineWand devices to treat soft tissue conditions in the spine; Plasma Disc Decompression SpineWands for treating contained herniated discs; Cavity SpineWand to reduce the size of malignant lesions in the vertebrae of patients suffering from spinal compression fractures; and WoundWand for wound debridement and wound cleansing by removal of necrotic tissue. The company sells its products to surgeons and specialized medical professionals through sales representatives, and independent sales agents and distributors. The company was founded in 1993 and is headquartered in Austin, Texas. As of May 29, 2014, ArthroCare Corporation operates as a subsidiary of Smith & Nephew, Inc.

Contact Information

Address 7000 West William Cannon Drive Building 1
Austin, 78735
United States
Phone 512-391-3900
Fax 512-391-3901
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ARTC Price Commentary

Write your thoughts about ArthroCare Corporation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email